Identifying subgroups with differential response to CBASP versus Escitalopram during the first eight weeks of treatment in outpatients with persistent depressive disorder.
Eur Arch Psychiatry Clin Neurosci
; 274(3): 723-737, 2024 Apr.
Article
en En
| MEDLINE
| ID: mdl-37606728
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Terapia Cognitivo-Conductual
/
Trastorno Depresivo
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Límite:
Female
/
Humans
Idioma:
En
Año:
2024
Tipo del documento:
Article